These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6997667)

  • 21. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
    Beck FW; Sowers JR; Sicca D; Welch BG
    Life Sci; 1985 Jun; 36(25):2435-44. PubMed ID: 2989637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
    Coruzzi P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
    Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
    Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
    Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
    J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
    Krishna GG; Chusid P; Hoeldtke RD
    Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of metoclopramide and L-dopa on a single dose metyrapone test in normal men.
    Matsuki M; Nishida S; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
    Horm Metab Res; 1983 Oct; 15(10):519-21. PubMed ID: 6315558
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of neostigmine on metoclopramide-induced aldosterone secretion in man.
    Sommers DK; Meyer EC; van Wyk M
    Eur J Clin Pharmacol; 1989; 36(4):411-3. PubMed ID: 2737235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
    Norbiato G; Bevilacqua M; Raggi U; Micossi P; Nitti F; Lanfredini M; Barbieri S
    J Clin Endocrinol Metab; 1979 Jan; 48(1):37-42. PubMed ID: 422703
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of renin and aldosterone in hypertension due to a renin-secreting tumor.
    Schambelan M; Howes EL; Noakes CA; Biglieri EG
    Am J Med; 1973 Jul; 55(1):86-92. PubMed ID: 4715934
    [No Abstract]   [Full Text] [Related]  

  • 31. [The dopaminergic system and aldosterone secretion. II. Effect of L-dopa and dexamethasone on aldosterone biosynthesis].
    Frisina N; Buemi M; Lasco A; Vitulo F; Ciraolo O; Costa G; Nicita-Mauro V
    Boll Soc Ital Biol Sper; 1980 Nov; 56(22):2290-6. PubMed ID: 7013772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metoclopramide does not elevate aldosterone in the rat.
    Campbell DJ; Mendelsohn FA; Adam WR; Funder JW
    Endocrinology; 1981 Nov; 109(5):1484-91. PubMed ID: 7297486
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of renin on aldosterone secretion in the rat.
    Masson GM; Travis RH
    Can J Physiol Pharmacol; 1968 Jan; 46(1):11-4. PubMed ID: 5642433
    [No Abstract]   [Full Text] [Related]  

  • 34. Metoclopramide-induced changes in plasma aldosterone "in vivo" are independent from renin-angiotensin system activity.
    Bernardi M; De Palma R; Trevisani F; Malatesta R; Gasbarrini G
    Horm Metab Res; 1988 Aug; 20(8):532-4. PubMed ID: 3053390
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
    Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
    Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of pentobarbitalnatrium (Nembutal) narcosis on blood pressure, plasma renin activity, aldosterone, sodium and potassium in normotensive and spontaneously hypertensive rats.
    Dimitrov TG; Kiprov DI; Maleeva AI; Terziyska SA
    C R Acad Bulg Sci; 1977; 30(11):1653-6. PubMed ID: 608409
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)].
    Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.